biotech investing

The Aussie biotech space is small but mighty – what will it take to see it surge?

Dr Bianca Ogden and Hashan De Silva share the companies and trials they find interesting in the constantly innovating biotech sector.

LTR Pharma is a clinical-stage pharmaceutical company, commercialising a world first in erectile dysfunction, Spontan, a PDE5 nasal spray.

Uncovering hidden gems amidst the sea of opportunities often requires a keen eye for potential change and growth catalysts.

Far from simply coming home with a wet sail in 2023, the biotech market is only just beginning to warm up for 2024.

In this wire we go beyond the immediate opportunity in diagnostics and review the landscape for prostate cancer radiotherapeutics.

After coronavirus vaccines made biotech the standout performer in 2020, the sector has faced a major reckoning this year. So is now the time to snatch up a bargain? In...

Horizon 3 Biotech is an AU$100m venture capital fund investing to improve lives globally through investments in public and private later-stage companies targeting a...

We don’t know if CIO Matt McNamara actually Iikes saying ‘no’ quite as much as he has to, but the success of Horizon 3 Biotech depends on it. Of the three to five...

When is the perfect time to invest in a company, and how do you decide? Jumping in with an early-stage company that is burning with potential can bring enormous...

Biotech is a booming sector currently worth US$755 billion and forecast to be triple that by 2028. This is all very well but what exactly is Biotech? It's about genes,...

Like all good venture capitalists, I started my career in the trenches working on the front line of my target industry, as a molecular biologist at LaTrobe University....